As of 2025-06-13, the EV/EBITDA ratio of Beam Therapeutics Inc (BEAM) is -3.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BEAM's latest enterprise value is 1,225.86 mil USD. BEAM's TTM EBITDA according to its financial statements is -407.00 mil USD. Dividing these 2 quantities gives us the above BEAM EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 13.8x | 13.1x |
| Forward P/E multiples | 20.6x - 43.4x | 32.0x |
| Fair Price | (44.94) - 743.46 | 250.89 |
| Upside | -357.7% - 4162.9% | 1338.6% |
| Date | EV/EBITDA |
| 2025-06-06 | -3.29 |
| 2025-06-05 | -2.90 |
| 2025-06-04 | -2.94 |
| 2025-06-03 | -2.87 |
| 2025-06-02 | -2.70 |
| 2025-05-30 | -2.61 |
| 2025-05-29 | -2.74 |
| 2025-05-28 | -2.87 |
| 2025-05-27 | -2.91 |
| 2025-05-23 | -2.86 |
| 2025-05-22 | -2.96 |
| 2025-05-21 | -2.96 |
| 2025-05-20 | -3.09 |
| 2025-05-19 | -3.07 |
| 2025-05-16 | -3.12 |
| 2025-05-15 | -2.96 |
| 2025-05-14 | -2.96 |
| 2025-05-13 | -3.16 |
| 2025-05-12 | -3.21 |
| 2025-05-09 | -3.00 |
| 2025-05-08 | -2.96 |
| 2025-05-07 | -2.71 |
| 2025-05-06 | -2.65 |
| 2025-05-05 | -3.60 |
| 2025-05-02 | -3.70 |
| 2025-05-01 | -3.60 |
| 2025-04-30 | -3.63 |
| 2025-04-29 | -3.57 |
| 2025-04-28 | -3.60 |
| 2025-04-25 | -3.53 |
| 2025-04-24 | -3.69 |
| 2025-04-23 | -3.61 |
| 2025-04-22 | -3.43 |
| 2025-04-21 | -3.21 |
| 2025-04-17 | -2.90 |
| 2025-04-16 | -2.81 |
| 2025-04-15 | -2.97 |
| 2025-04-14 | -2.90 |
| 2025-04-11 | -2.53 |
| 2025-04-10 | -2.32 |
| 2025-04-09 | -2.75 |
| 2025-04-08 | -2.30 |
| 2025-04-07 | -2.48 |
| 2025-04-04 | -2.48 |
| 2025-04-03 | -2.77 |
| 2025-04-02 | -3.27 |
| 2025-04-01 | -3.06 |
| 2025-03-31 | -3.53 |
| 2025-03-28 | -4.19 |
| 2025-03-27 | -4.19 |